Management is doing things right; leadership is doing the right things. ~ Peter Drucker

Eileen Jennings-Brown(Eileen), Head of Technology, Wellcome Trust shares the factors that make up the decision on what Cloud provider to choose. 📢Stream 'In 2022, What Cloud Is Right For You?' here: hubs.la/Q01bJp6v0 Filmed in partnership with HPE.

What’s the state of #AI and drug discovery? Tomorrow, our founder and CEO, Andrew Hopkins, DPhil., will share his insights as part of a #FierceNextGen virtual panel hosted by Fierce Life Sciences Events. Tune in to hear how recent successes showcase AI’s potential to be a gamechanger.

Great to see our Founder & CEO, Andrew Hopkins, featured in The Observer by Julia Kollewe describing the origins of the company and his vision for the future. theguardian.com/business/2022/… #AI #drugdiscovery

Are you listening to next week’s summit, The State of Biotech, hosted by Genetic Engineering & Biotechnology News? Our CEO Andrew Hopkins, will join industry leaders to discuss the latest breakthroughs, trends and challenges in AI. Learn more: bit.ly/3Lm1tNf #StateofBiotech22

Check out the #moleculardynamics in #pharma meeting, in March, organised by William Glass and Benjamin Cossins to learn more about key developments in MD applied to the pharmaceutical industry

Hi folks, I’m afraid it’s time for me to say goodbye. Not just leaving Twitter, but the whole show. I’ve been battling cancer last 2 years, but now only have a few days left now. Thank you wonderful people, I leave this crazy world with much love in my heart ❤️

Hear from Dave Hallett our CSO, and Garry Pairaudeau, our CTO to learn more about the evolution of Exscientia’s technology and how this allowed us to deliver differentiated LSD1 and MALT1 inhibitors against challenging design criteria: bit.ly/LSD1-MALT1_vid…

This is significant news… these are unique compounds.

Don’t miss our CIO Eileen Jennings-Brown Eileen discussing ‘The promise of #AI in biotech’. Join the waitlist here: inthecloud.withgoogle.com/somx-healthtec…

Don’t miss Exscientia's CIO Eileen Jennings-Brown Eileen discussing ‘The promise of #AI in biotech’ - supported by SomX & Google Cloud; $EXAI

Superb news!

Learn Exscientia CEO Andrew Hopkins’ thoughts on present and future opportunities and limitations of #AI in #pharmaceutical development in this brand new piece by Pharmaceutical Executive

We're delighted to announce the expansion of our collaboration with Sanofi to include an existing, new discovery stage programme, initially identified and advanced by Exscientia. Learn more: investors.exscientia.ai/press-releases…

Thank you for the recognition and shout out to the great teams we all get to work with. This one’s for you all. You know who you are. 😄 #teamwork #ai #technology

“Know your worth — knowing your value matters, so speak out, stand up for yourself, and promote the work of other women.” Great advice from our CIO Eileen, in her Authority Magazine Wisdom From The Women Leading The AI Industry interview medium.com/authority-maga…

Thank you Eileen for the amazing interview!

Our end-to-end AI-driven precision medicine platform has been nominated in the Best Digital Health Solution category of the Prix Galien International 2024 awards. We’re honoured to be recognised by the The Galien Foundation among fellow innovators. #AI #precisionmedicine #PrixGalien

Watch this insightful interview with Rich Law explaining how we’re using AI aiming to discover high-quality drug candidates, faster. #AI #precisionmedicine #drugdiscovery

Watch this informative interview with Dave Hallett speaking to @biotechtvhq, delving into the details of our pipeline, upcoming developments and discussing the integration of our lab research and AI capabilities. biotechtv.com/post/exscienti… #AI #drugdevelopment #oncology